Methaemoglobinaemia

Methaemoglobinaemia

  • Definition: Excessive methaemoglobin in blood
    • Altered state of Hb where ferrous (Fe2+) is oxidised to ferric state (Fe3+) and unable to bind O2
    • Normal level <1.5%

Causes

  • Congenital
    • Cytochrome b5 reductase deficiency
    • Haemoglobin M disease
  • Acquired
    • Aniline dyes
    • Benzene derivatives
    • Chloroquine
    • Dapsone
    • Prilocaine and lignocaine (not dose-dependent and more common in children)
    • Metoclopramide
    • Nitrites (nitroglycerine, NO, sodium nitroprusside, amyl nitrate, alkyl nitrates)
    • Sulphonamides
    • Rifampicin
    • Sodium chlorite/chlorate

Methaemoglobinaemia

  • Clinical presentation
    • Cyanosis with grey-blue skin discolouration
    • Reduced oxygen delivery e.g. chest pain, SOB, altered mental state
    • SpO2 85-90%
      • Methaemoglobin absorbs light similarly to HbO and sats nadir at 85%
    • Chocolate brown blood that remains brown on exposure to air
    • Normal PaO2 (as measures dissolved)
    • Co-oximetry measures true HbO2 and metHb in order to confirm
  • Ix
    • ABG confirmation (co-oximetry +/- specific assay + history of exposure)
    • High metHb

Methaemoglobinaemia

  • Management
    • High flow O2 (to maximise functional Hb saturation)
    • Cessation/avoidance of precipitants
    • Methylene blue
      • 1-2mg/kg over 5 minutes
      • Artificial electron acceptor to reduce MetHb via NADPH-dependent pathway
      • Indications: Symptomatic, >20% MetHb or >10% and hx of anaemia/IHD
      • Repeat at 30-60min as required
    • Alternatives
      • Ascorbic acid (e.g. used in G6PD deficiency when methylene blue contraindicated)
      • Exchange transfusion
      • Hyperbaric oxygen

Methaemoglobinaemia

  • What if methylene blue fails?
    • Massive ongoing exposure to oxidising agent
    • Sulfhaemoglobinaemia (e.g. dapsone, sulfonamides)
    • G6PD deficiency
    • Methaemoglobin reductase deficiency
    • Abnormal Hb
    • Excessive methylene blue (paradoxical effect in high doses)

Last Updated on October 14, 2020 by Andrew Crofton